Generate Biomedicines, Inc. (GENB) — Analyst estimates
Consensus analyst estimates for Generate Biomedicines, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 7.05M | -0.57 | 1 |
| 2027 | 4.42M | -0.49 | 1 |
| 2028 | 92.23M | -1.73 | 2 |
| 2029 | 22.50M | -2.81 | 1 |
| 2030 | 163.2M | -2.45 | 1 |
Consensus analyst estimates by fiscal year.